Appetite control becomes more pronounced, portion sizes decrease naturally, and cravings for high-calorie foods diminish
While GLP-1 costs remain higher than bariatric surgery, retail prices will come down over time, especially in 2032 (when initial patents run out and generics appear), but probably not to the level of Dexatrim, phen-phen and similar blockbuster, yet faddish, weight-loss pills from yesteryear
Diabetic ketoacidosis (DKA) risk is a serious concern, particularly for patients using insulin or SGLT2 inhibitors with very-low-carbohydrate diets
We first asked participants whether they thought the growing popularity of GLP-1 drugs will change Americans dietary preferences and food purchasing habits
10.1053/j.ajkd.2024.08.002 82 TengholmA.GylfeE
If someone is on semaglutide and we switch them to tirzepatide, often, theyre going to experience more weight loss. But she notes that the response can vary from person to person